| Identifier |
20230314_nanos_posters_306 |
| Title |
The Role of Teprotumumab in the Treatment of Diplopia Due to Thyroid Eye Disease |
| Creator |
Shwetha Mudalegundi; Peng Huang; Amanda Henderson; Andrew Carey |
| Affiliation |
(SM) (PH) (AH) Wilmer Eye Institute, Johns Hopkins; (AC) Wilmer Eye Institute, Johns Hopkins University School of Medicine |
| Subject |
Graves' Disease; Adult Strabismus; Diplopia; Miscellaneous |
| Description |
Thyroid Eye Disease (TED) is a vision threatening condition caused by inflammatory damage to the periocular tissue. Teprotumumab is an IGF-1R antibody that was FDA approved for the management of TED in 2020, although much is yet to be elucidated regarding its effects on diplopia outcomes among TED patients. Diplopia is a significant and life altering effect of TED. Prior studies have reported teprotumumab's effect on double vision subjectively using the Gorman diplopia score. However, there is a gap in the literature addressing the effect of teprotumumab treatment on objective ocular alignment measures, and this is what we aim to address. |
| Date |
2023-03-14 |
| Language |
eng |
| Format |
application/pdf |
| Type |
Text |
| Source |
2023 North American Neuro-Ophthalmology Society Annual Meeting |
| Relation is Part of |
NANOS Annual Meeting 2023: Poster Session II: Neuro-Ophthalmic Practice |
| Collection |
Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/ |
| Publisher |
North American Neuro-Ophthalmology Society |
| Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Rights Management |
Copyright 2023. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
| ARK |
ark:/87278/s6xarmk4 |
| Setname |
ehsl_novel_nam |
| ID |
2335511 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6xarmk4 |
